Consequently, 27% of sporadic schwannomatosis patients who do not exhibit germline NF2, SMARCB1, and LZTR1 mutations, but who do display tumour-specific biallelic NF2 inactivation, could, in principle, be caused by mutations in hitherto unidentified gene(s). This evidence concerns the gene LZTR1 and neoplasm.